Chen, Xiaoling,Yu, Henry,Lan, Ruoxi,Jorand-Lebrun, Catherine,Johnson, Theresa L.,Goutopoulos, Andreas
申请号：
AU2016215185
公开号：
AU2016215185A1
申请日:
2016.02.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors. Wherein: Ring A is a 5-membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5- membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur； each of which is optionally substituted； Ring B is a 6-membered aryl, or a 6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur； each of which is optionally substituted； Ring C is a 5-membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5- membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur； each of which is optionally substituted.
